Cellectar Biosciences - Stock Price History | CLRB
Historical daily share price chart and data for Cellectar Biosciences since 2020 adjusted for splits. The latest closing stock price for Cellectar Biosciences as of June 03, 2020 is 1.03.
- The all-time high Cellectar Biosciences stock closing price was 1040000.00 on November 30, 2005.
- The Cellectar Biosciences 52-week high stock price is 3.33, which is 223.3% above the current share price.
- The Cellectar Biosciences 52-week low stock price is 1.01, which is 1.9% below the current share price.
- The average Cellectar Biosciences stock price for the last 52 weeks is 1.95.
| Cellectar Biosciences Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 2.0526 | 1.5800 | 2.8500 | 1.0600 | 2.2500 | 45.16% |
| 2018 | 7.0838 | 13.7000 | 13.7000 | 1.2900 | 1.5500 | -88.69% |
| 2017 | 17.2692 | 12.8000 | 26.6000 | 11.2000 | 13.7000 | 12.30% |
| 2016 | 31.0365 | 73.2000 | 76.1500 | 10.5000 | 12.2000 | -83.40% |
| 2015 | 250.6595 | 306.0100 | 355.0000 | 68.5000 | 73.5000 | -76.21% |
| 2014 | 552.5469 | 760.0000 | 840.0000 | 198.9500 | 309.0000 | -58.24% |
| 2013 | 910.9524 | 1480.0000 | 1580.0000 | 600.0000 | 740.0000 | -50.00% |
| 2012 | 1921.5200 | 900.0000 | 4000.0000 | 860.0000 | 1480.0000 | 68.18% |
| 2011 | 4329.3590 | 12307.6923 | 15384.6154 | 740.0000 | 880.0000 | -90.47% |
| 2010 | 114261.2943 | 913846.1538 | 913846.1538 | 6153.8462 | 9230.7692 | -98.82% |
| 2009 | 217191.6972 | 144615.3846 | 781538.4615 | 104615.3846 | 781538.4615 | 440.43% |
| 2008 | 159464.8829 | 187692.3077 | 246153.8462 | 67692.3077 | 144615.3846 | -21.67% |
| 2007 | 262298.4983 | 276923.0769 | 418461.5385 | 132307.6923 | 184615.3846 | -31.82% |
| 2006 | 376647.2571 | 584615.3846 | 695384.6154 | 193846.1538 | 270769.2308 | -56.44% |
| 2005 | 775736.2637 | 840000.0000 | 1040000.0000 | 498461.5385 | 621538.4615 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.012B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $163.830B | 28.41 |
| Medtronic (MDT) | Ireland | $130.331B | 21.19 |
| Stryker (SYK) | United States | $74.362B | 24.14 |
| Boston Scientific (BSX) | United States | $52.532B | 24.70 |
| Baxter (BAX) | United States | $46.146B | 28.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $36.460B | 0.00 |
| Terumo (TRUMY) | Japan | $30.335B | 0.00 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.429B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $26.519B | 16.69 |
| ResMed (RMD) | United States | $23.112B | 36.47 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $18.370B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.252B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $14.618B | 66.54 |
| Insulet (PODD) | United States | $11.765B | 1165.63 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.630B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.366B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.685B | 13.75 |
| Quidel (QDEL) | United States | $7.081B | 55.64 |
| Hill-Rom Holdings (HRC) | United States | $6.783B | 19.12 |
| William Demant Holdings (WILYY) | Denmark | $6.670B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.590B | 34.05 |
| Canopy Growth (CGC) | Canada | $5.662B | 0.00 |
| Haemonetics (HAE) | United States | $5.428B | 32.60 |
| ICU Medical (ICUI) | United States | $4.102B | 29.92 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.935B | 0.00 |
| Neogen (NEOG) | United States | $3.757B | 63.63 |
| Agios Pharmaceuticals (AGIO) | United States | $3.602B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 0.00 |
| NuVasive (NUVA) | United States | $3.226B | 25.90 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.985B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.196B | 37.99 |
| TG Therapeutics (TGTX) | United States | $2.063B | 0.00 |
| AtriCure (ATRC) | United States | $1.801B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.478B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.341B | 0.00 |
| Aphria (APHA) | Canada | $1.203B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.183B | 0.00 |
| MacroGenics (MGNX) | United States | $1.079B | 0.00 |
| Cerus (CERS) | United States | $1.051B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.038B | 20.70 |
| InMode (INMD) | Israel | $0.992B | 20.97 |
| PetIQ (PETQ) | United States | $0.847B | 24.46 |
| Omeros (OMER) | United States | $0.813B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.768B | 130.08 |
| Quanterix (QTRX) | United States | $0.762B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.752B | 151.38 |
| VAREX IMAGING (VREX) | United States | $0.749B | 18.59 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.718B | 51.43 |
| Zynex (ZYXI) | United States | $0.650B | 65.23 |
| Meridian Bioscience (VIVO) | United States | $0.645B | 24.27 |
| Lantheus Holdings (LNTH) | United States | $0.560B | 11.26 |
| Vapotherm (VAPO) | United States | $0.556B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.535B | 30.49 |
| Surmodics (SRDX) | United States | $0.517B | 62.31 |
| Owens & Minor (OMI) | United States | $0.481B | 12.73 |
| Repro-Med Systems (KRMD) | United States | $0.425B | 357.00 |
| BioLife Solutions (BLFS) | United States | $0.417B | 146.00 |
| Cytosorbents (CTSO) | United States | $0.376B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.373B | 27.09 |
| Viemed Healthcare (VMD) | United States | $0.324B | 29.03 |
| Organigram Holdings (OGI) | Canada | $0.316B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.285B | 0.00 |
| HEXO (HEXO) | $0.267B | 0.00 | |
| Female Health (VERU) | United States | $0.237B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.236B | 130.78 |
| Chimerix (CMRX) | United States | $0.204B | 0.00 |
| Evolus (EOLS) | United States | $0.161B | 0.00 |
| Fonar (FONR) | United States | $0.158B | 13.98 |
| Chembio Diagnostics (CEMI) | United States | $0.155B | 0.00 |
| Bovie Medical (APYX) | United States | $0.150B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.146B | 0.00 |
| Exagen (XGN) | United States | $0.142B | 0.00 |
| Surface Oncology (SURF) | United States | $0.140B | 0.00 |
| United Health Products (UEEC) | United States | $0.137B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.135B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.124B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.108B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 18.62 |
| Brainsway (BWAY) | Israel | $0.079B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.078B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.074B | 0.00 |
| Nephros (NEPH) | United States | $0.070B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.069B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.044B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.033B | 0.00 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.028B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.022B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.014B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
